Patents in Class 560/34

Matches 1 - 50 out of 400

1 2 3 4 5 6 7 8 >

Match	Document	Document Title
1	8058449	*WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST* Heterodimers of glutamic acid Compounds of Formula (Ia) wherein R is a C6-C12 substituted or unsubstituted aryl, a C6-C12 substituted or unsubstituted heteroaryl, a C1-C6 substituted or unsubstituted alkyl or —NR′R′, Q is C(O),...
2	7973063	Methods for activating PPAR gamma-type receptors Novel biaromatic compounds having the following structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, in particular in...
3	7956216	Alpha-helical mimetics Benzoyl urea derivatives that are alpha helical peptides mimetics that mimic BH3-only proteins, compositions containing them, their conjugation to cell-targeting-moieties, and their use in the...
4	7863332	Biaromatic compound activators of PPARγ receptors and cosmetic/pharmaceutical compositions comprised thereof Novel biaromatic compounds having the general formula (I): and cosmetic/pharmaceutical compositions comprised thereof are useful in human or veterinary medicine (in dermatology and also in the...
5	7825279	Fused ring dicationic anti-protozoan agents and their prodrugs Novel fused ring dicationic anti-protozoan compounds. Representative protozoan species include but are not limited to Trypanosoma brucei rhodesiense (T.b.r.) and Plasmodium falciparum. Prodrugs of...
6	7777069	Prodrugs of carbamate inhibitors of IMPDH The present invention relates to novel compounds, methods of preparing these compounds, and pharmaceutical compositions comprising these compounds. These compounds are carbamate prodrugs that...
7	7659424	Process for the allylation of n-acylhydrazones [PROBLEMS] To provide a novel method for the allylation of N-acylhydrazones by which enantioselectively allylated N-acylhydrazines can be efficiently obtained. [MEANS FOR SOLVING PROBLEMS] A method...
8	7626054	Biaromatic compounds which activate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprised thereof Novel biaromatic compounds having the following structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, in particular in...
9	7608621	N-substituted glycine derivatives: hydroxylase inhibitors The invention described herein relates to certain pyridazinedione N-substituted glycine derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating...
10	7476762	Methods for preparing sulfonamide compounds Methods for preparing substituted phenylsulfonamide compounds of the following structure are provided: or a pharmaceutically acceptable salt thereof, wherein, R1-R7 are defined herein. Also...
11	7449446	Combination product comprising melagatran and dexamethasone There is provided a combination product comprising; (A) melagatran or a pharmaceutically acceptable derivative thereof; and (B) dexamethasone or a pharmaceutically acceptable derivative there of,...
12	7408079	Imaging agents and methods of imaging NAALADase or PSMA The present invention relates to compounds particularly asymmetric urea compounds which are labeled with one or more radioisotopes and which are suitable for imaging or therapeutic treatment of...
13	7253171	Urea derivatives as integrin α4 antagonists Novel antagonists of ∝4β1 integrin and/or ∝4β7 integrin of the general Formula I: wherein R1, R2, R5, L1, L2, Rb, W and Z are as defined in any one of claims 1 to 13, A represents —CH— or a nitroge...
14	7235672	Probe, assay and kits for detecting 11β-hydroxysteroid dehydrogenase and modulators thereof A probe, kit comprising the probe, and methods for using the probe are provided where the probe comprises: whereinDM is a detectable marker; andL is a straight or branched chain moiety providing...
15	7199265	Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones This invention relates to compounds of the formula (I) which are thyroid receptor ligands, and are preferably selective for the thyroid hormone receptor β, to methods of preparing such compounds ...
16	7144665	Organophotoreceptor with a charge transport material having two hydrazone groups Improved organophotoreceptor comprises an electrically conductive substrate and a photoconductive element on the electrically conductive substrate, the photoconductive element comprising: (a) a...
17	7101912	Carbidopa prodrugs and derivatives, and compositions and uses thereof Prodrugs of carbidopa, derivatives of carbidopa prodrugs, methods of making prodrugs of carbidopa and derivatives thereof, methods of using prodrugs of carbidopa and derivatives thereof, and...
18	7098247	Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives The present invention describes compounds of the general formula I as well as processes for their manufacture, pharmaceutical compositions containing them and methods for using these compounds and...
19	7049341	N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use N-Benzoylureidocinnamic acid derivatives, processes for preparing them and their use The invention relates to N-benzoylureidocinnamic acid derivatives and to their physiologically tolerated salts...
20	7034015	Aminobenzoephenones The invention relates to a novel class of aminobenzophenones derivatives, to pharmaceutical preparations comprising said compounds, to dosage units of such preparations, to methods of treating...
21	6962905	Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug A kit of parts containing (a) a pharmaceutical formulation including a low molecular weight thrombin inhibitor, or a pharmaceutically acceptable derivative thereof, in admixture with a...
22	6875884	Urea derivatives as inhibitors for CCR-3 receptor Urea and thiourea derivatives inhibit cell function of the chemokine receptor CCR-3. These compounds offer an effective means for treating a range of diseases thought to be mediated by the CCR-3...
23	6838472	Substituted urea retinoid agonists The current invention provide novel compounds, methods of treating or preventing emphysema, cancer and dermatological disorders, pharmaceutical compositions suitable for the treatment or prevention...
24	6734212	Methods and compositions for treating or preventing bacterial infection The invention relates to compositions and methods for treating or preventing disease or disorders caused by or associated with certain bacterial infection, especially Escherichia coli (E. coli) or...
25	6683200	N-substituted-N′-substituted urea derivatives and pharmaceutical compositions containing the derivatives N-Substituted-N′-substituted urea derivatives represented by the following formula, analogs thereof or pharmaceutically acceptable salts thereof are herein provided. These compounds show a TNF-α pr...
26	6593315	Salicylic acid derivatives, processes for their preparation, compositions comprising them, and their use Salicylic acid derivatives of the formula I, where the index and the substituents have the following meanings:X is halogen, NO2, cyano, alkyl or alkoxy;m is 0, 1, 2 or 3, it being possible for the...
27	6552216	Molecular model for VLA-4 inhibitors Pharmacophore models of VLA-4 inhibitors, methods of identifying novel inhibitors and novel inhibitors identified by these methods.
28	6545029	Phenylserine derivatives as integrin antagonists The present invention relates to new phenylserine derivatives as integrin antagonists with a broad spectrum of action having, inter alia, antiosteoporotic, antirestenotic, anticarcinogenic and...
29	6534283	Method for treatment and prevention of physiological shock Shock is a life threatening complication in situations associated with trauma including burns, surgery, ischemia, sepsis, and other critical care applications. Shock is induced by pancreatic...
30	6534546	Aniline derivatives possessing an inhibitory effect of nitric oxide synthase Compounds represented by the general formula (1): (where R1 is SR6 or NR7R8, where R6 is typically an alkyl group having 1-6 carbon atoms, R7 is a hydrogen atom, an alkyl group having 1-6 carbon a...
31	6504045	Crystal polymorphs of a yellow disazo colorant, and their preparation The invention relates to six new crystal polymorphs, α (alpha), β (beta), γ (gamma), δ (delta), ζ (zeta), and η (eta), of the disazo colorant of the formula I, having characteristic refle...
32	6465686	Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors The present invention discloses halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors.
33	6458986	Intermediate for (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo&lsqb 1,2-α&rsqb imidazol-2-one A novel process for the preparation of (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl -1-H-imidazo[1,2-α]imidazol-2-one (1): This compound is useful as an intermediate in the ...
34	6459001	Tricyclic compounds, their preparation process and the intermediates of this process, their use as medicaments and the pharmaceutical compositions containing them The subject of the invention is the products of formula (I): in which R1, R2, R3, R4, R5 and G are as defined in the description, the dotted lines represent an optional second bond, as well as the...
35	6433017	Amphiphilic polyamine compounds In accordance with the present invention, there are provided amphiphilic polyamine compounds and derivatives thereof having the property of promoting transfection of polynucleotides and...
36	6417393	Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers The present patent application relates to compounds having formula (I) or a pharmaceutically acceptable salt thereof wherein one of R1, R2 and R3 is a non-cyclic acidic group having a pKa value...
37	6403794	Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides The invention relates to novel substituted 2-amino-4-alkylamino-1,3,5-triazines of the formula (I) in whichR1 represents in each case optionally substituted alkyl having 2 to 6 carbon atoms or...
38	6391917	Dialkyl ureas as calcitonin mimetics Dialkyl urea compounds are described which act as calcitonin mimetics. These compounds are useful in the treatment of diseases which are associated with bone resorption. The calcitonin mimetics of...
39	6388122	Tryptase inhibitor and novel guanidino derivatives A tryptase inhibitor comprising as an active ingredient at least one member selected from among guanidinoaliphatic acid derivatives of the formula (I), guanidinobenzoic acid derivatives of the...
40	6376699	Process for preparing alkoxytriazolinones Hydroazinecarboxylic acid ester of the formula In which R1 is an optionally substituted alkyl group, an aryl group, an arylalkyl group or a cycloalkyl group, and R3 is an optionally substituted...
41	6365745	Method for producing hydrazine derivative The present invention provides a method for producing a hydrazine derivative of the formula [2]: wherein R1 is alkyl group having 1-12 carbon atoms and the like, R2 is alkyl group having 1-12...
42	6348499	Amphiphilic polyamide compounds Amphiphilic polyamide compounds and derivatives thereof having the property of promoting transfection of polynucleotides and polypeptides into cells, and formulations comprising said compounds.
43	6344484	Tyrosine alkoxyguanidines as integrin inhibitors The present invention relates to novel tyrosine alkoxyguanidine compounds that are inhibitors of alpha V (αv) integrins, for example αvβ3 and αvβ5 integrins, their pharmaceutically acceptable salt...
44	6310074	Substituted dimeric compounds The invention relates to compound of formula (I): A--G1 --Cy--G2 --Cy'--G3 --B (I)wherein: A represents a grouping NR1 C(Q)R2, C(Q)NR2 R3 or NR1 C(Q)NR2 R3, B represents a grouping NR1 C(Q)R2, NR1...
45	6284914	Highly water-soluble metalloproteinase inhibitors New compounds of general formulae (III), (IV) and (V). ##STR1##
46	6252104	Naphthol derivatives and process for producing the same A naphthol derivative represented by the general formula (I), [wherein Y and Y' indicate --(CONH)n --X or --COR; X is a phenyl group, a naphthyl group, an anthraquinonyl group, a benzimidazolonyl...
47	6242609	Method for manufacturing a color coupler used in a silver halide photographic light-sensitive material A method for manufacturing a color coupler used in a silver halide photographic light-sensitive material using an ammonium trihalide.Said method for manufacturing the color coupler comprising the...
48	6229011	N-aroylphenylalanine derivative VCAM-1 inhibitors Compounds of the formula: ##STR1##are disclosed which have activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose...
49	6229047	Dipole aligned NLO chromophores A nonlinear optical material which is characterized as having a relatively high macroscopic dipole moment achieved through the generally parallel packing of dipolar molecules in a relative...
50	6221907	Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same

Matches 1 - 50 out of 400

1 2 3 4 5 6 7 8 >